UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical presentation and prognosis in MOG-antibody disease: a UK study

Brain (London, England : 1878), 2017-12, Vol.140 (12), p.3128-3138

2017

Volltextzugriff (PDF)

Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis

Multiple sclerosis, 2022-02, Vol.28 (2), p.217-227

2022

Volltextzugriff (PDF)

Mitochondrial diseases mimicking NMOSD

Multiple sclerosis, 2023-06, Vol.29 (7), p.897-898

Juryńczyk, Maciej

2023

Volltextzugriff (PDF)

Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis

Journal of neurology, neurosurgery and psychiatry, 2017-02, Vol.88 (2), p.165-169

2017

Volltextzugriff (PDF)

295 Clinical outcome in mog-antibody disease: a large single site cohort

Journal of neurology, neurosurgery and psychiatry, 2018-10, Vol.89 (10), p.A46-A47

2018

Volltextzugriff (PDF)

Double-negative neuromyelitis optica spectrum disorder

Multiple Sclerosis Journal, 2023-10, Vol.29 (11-12), p.1353-1362

2023

Volltextzugriff (PDF)

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations

Practical neurology, 2019-06, Vol.19 (3), p.187-195

2019

Volltextzugriff (PDF)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease

Acta neuropathologica communications, 2017-12, Vol.5 (1), p.95-13, Article 95

2017

Volltextzugriff (PDF)

Spinal cord and brain MRI should be routinely performed during follow-up in patients with NMOSD – No

Multiple sclerosis, 2021-01, Vol.27 (1), p.15-16

2021

Volltextzugriff (PDF)

Overlapping CNS inflammatory diseases: differentiating features of NMO and MS

Journal of Neurology, Neurosurgery and Psychiatry, 2015-01, Vol.86 (1), p.20-25

2015

Volltextzugriff (PDF)

Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease

Journal of neurology, neurosurgery and psychiatry, 2017-02, Vol.88 (2), p.132-136

2017

Volltextzugriff (PDF)

Relapsing antibody-negative patients with features of neuromyelitis optica spectrum disorders: Differences in N-acetylaspartate level in the cervical spinal cord indicate distinct underlying processes

Multiple sclerosis, 2022-12, Vol.28 (14), p.2221-2230

2022

Volltextzugriff (PDF)

Elucidating distinct clinico-radiologic signatures in the borderland between neuromyelitis optica and multiple sclerosis

Journal of neurology, 2022-01, Vol.269 (1), p.269-279

2022

Volltextzugriff (PDF)

Notch: A new player in MS mechanisms

Journal of neuroimmunology, 2010-01, Vol.218 (1), p.3-11

2010

Volltextzugriff (PDF)

Increasing role of imaging in differentiating MS from non-MS and defining indeterminate borderline cases

Neurologia i neurochirurgia polska, 2022-01, Vol.56 (3), p.210-219

2022

Volltextzugriff (PDF)

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease

Neurology : neuroimmunology & neuroinflammation, 2015-06, Vol.2 (3), p.e89-e89

2015

Volltextzugriff (PDF)

Immune regulation of multiple sclerosis by transdermally applied myelin peptides

Annals of neurology, 2010-11, Vol.68 (5), p.593-601

2010

Volltextzugriff (PDF)

Natalizumab and the development of extensive brain lesions in neuromyelitis optica

Journal of neurology, 2013-07, Vol.260 (7), p.1919-1921

2013

Volltextzugriff (PDF)

The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease

Multiple sclerosis, 2021-05, Vol.27 (6), p.968-972

2021

Volltextzugriff (PDF)

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes

Journal of neurology, 2016-01, Vol.263 (1), p.140-149

2016

Volltextzugriff (PDF)

Distinct influence of different vascular risk factors on white matter brain lesions in multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2020-04, Vol.91 (4), p.388-391

2020

Volltextzugriff (PDF)

008 Systemic inflammatory response in relapsing-remitting multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2022-06, Vol.93 (6), p.A16-A16

2022

Volltextzugriff (PDF)

Towards imaging criteria that best differentiate MS from NMOSD and MOGAD: Large multi-ethnic population and different clinical scenarios

Multiple sclerosis and related disorders, 2022-05, Vol.61, p.103778-103778, Article 103778

2022

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical presentation and prognosis in MOG-antibody disease: a UK study

Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis

Mitochondrial diseases mimicking NMOSD

Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis

295 Clinical outcome in mog-antibody disease: a large single site cohort

Double-negative neuromyelitis optica spectrum disorder

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease

Spinal cord and brain MRI should be routinely performed during follow-up in patients with NMOSD – No

Overlapping CNS inflammatory diseases: differentiating features of NMO and MS

Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease

Relapsing antibody-negative patients with features of neuromyelitis optica spectrum disorders: Differences in N-acetylaspartate level in the cervical spinal cord indicate distinct underlying processes

Elucidating distinct clinico-radiologic signatures in the borderland between neuromyelitis optica and multiple sclerosis

Notch: A new player in MS mechanisms

Increasing role of imaging in differentiating MS from non-MS and defining indeterminate borderline cases

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease

Immune regulation of multiple sclerosis by transdermally applied myelin peptides

Natalizumab and the development of extensive brain lesions in neuromyelitis optica

Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease

The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes

Distinct influence of different vascular risk factors on white matter brain lesions in multiple sclerosis

008 Systemic inflammatory response in relapsing-remitting multiple sclerosis

Towards imaging criteria that best differentiate MS from NMOSD and MOGAD: Large multi-ethnic population and different clinical scenarios

Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis

Suchergebnisse filtern